Understanding the difference between a GLP-1 medication and its branded formulation
Explore Semaglutide TreatmentThis means the comparison is not between two different drugs, but between a medical ingredient (Semaglutide) and a brand product (Ozempic).
Semaglutide is the core GLP-1 therapy used for weight loss and type 2 diabetes management. Explore medically supervised options and pricing.
View Semaglutide Guide| Factor | Semaglutide (Active Ingredient) | Ozempic (Brand Name) |
|---|---|---|
| Definition | GLP-1 receptor agonist compound | Branded pharmaceutical product |
| Active Ingredient | Semaglutide | Semaglutide |
| Weight Loss Effect | 10–15% body weight reduction | 10–15% body weight reduction |
| Administration | Injection (varies by provider) | Weekly injection |
| Regulation | Varies (compounded / generic sourcing) | FDA-approved standardized product |
| Cost | Lower / flexible pricing | Higher branded cost |
| Primary Advantage | Accessibility & affordability | Consistency & clinical standardization |
Semaglutide and Ozempic are not fundamentally different drugs — Ozempic is simply a branded version of the Semaglutide molecule.
The real decision is not between two medications, but between:
Most weight loss protocols and GLP-1 treatment plans are built around Semaglutide as the core therapy.
View Dosage Guide Learn Side Effects